Techne Corporation Newswire

Techne Corporation Newswire

Comprehensive Real-Time News Feed for Techne Corporation.

Results 1 - 20 of 221 in Techne Corporation

  1. Bio-Techne Corp (TECH) Stake Decreased by Nuveen Asset Management LLCRead the original story w/Photo

    Yesterday | IntersportsWire

    ... stock valued at $1,146,707 in the last 90 days. 2.70% of the stock is owned by corporate insiders. Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The ...

    Comment?

  2. Zacks: Brokerages Anticipate Bio-Techne Corp (TECH) Will Announce Quarterly Sales of $149.49 MillionRead the original story w/Photo

    Wednesday | IntersportsWire

    Brokerages expect Bio-Techne Corp to announce $149.49 million in sales for the current quarter, according to Zacks Investment Research . Six analysts have provided estimates for Bio-Techne Corp's earnings.

    Comment?

  3. Bio-Techne Corp (TECH) Stake Held by Glenmede Trust Co. NARead the original story w/Photo

    Tuesday Jul 18 | Daily Political

    ... ny stock valued at $1,146,707 in the last 90 days. Company insiders own 2.70% of the company's stock. Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The

    Comment?

  4. Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Confluence Investment Management LLCRead the original story w/Photo

    Thursday Jul 13 | The Breeze

    ... d 10,300 shares of company stock worth $1,146,707. Company insiders own 2.70% of the company's stock. Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for

    Comment?

  5. Bio-Techne Corp (TECH) Receives New Coverage from Analysts at Wells Fargo & CompanyRead the original story w/Photo

    Thursday Jul 13 | IntersportsWire

    ... shares during the period. Institutional investors and hedge funds own 96.91% of the company's stock. Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The ...

    Comment?

  6. Bio-Techne To Host Conference Call On August 8, 2017 To Announce Fourth Quarter Financial ResultsRead the original story

    Tuesday Jul 11 | BioSpace

    ... and enter the replay access code 8032349. The recording can also be accessed by going to: Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteinsnotably cytokines and growth factors, ...

    Comment?

  7. PNC Financial Services Group Inc. Sells 2,403 Shares of Bio-Techne CorpRead the original story w/Photo

    Thursday Jul 6 | IntersportsWire

    ... shares of company stock valued at $1,145,136. Corporate insiders own 2.70% of the company's stock. Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The ...

    Comment?

  8. Bio-Techne Corp (NASDAQ:TECH) Upgraded at Zacks Investment ResearchRead the original story w/Photo

    Thursday Jul 6 | AmericanBankingNews.com

    ... points to a potential upside of 12.69% from the company's previous close. According to Zacks, "Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It ...

    Comment?

  9. Bio-Techne Corp (TECH) Shares Bought by Prudential Financial Inc.Read the original story w/Photo

    Wednesday Jul 5 | Daily Political

    ... at $1,145,136 over the last 90 days. 2.70% of the stock is currently owned by company insiders. Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The ...

    Comment?

  10. Bio-Techne Corp (TECH) Given Consensus Rating of "Buy" by AnalystsRead the original story w/Photo

    Monday Jul 3 | AmericanBankingNews.com

    Shares of Bio-Techne Corp have been assigned a consensus recommendation of "Buy" from the eight analysts that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company.

    Comment?

  11. Bio-Techne Corp (TECH) Shares Bought by Stifel Financial CorpRead the original story w/Photo

    Sunday Jul 2 | IntersportsWire

    Stifel Financial Corp increased its position in shares of Bio-Techne Corp by 11.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,928 shares of the biotechnology company's stock after buying an additional 913 shares during the period.

    Comment?

  12. Menta Capital LLC Acquires New Position in Bio-Techne CorpRead the original story w/Photo

    Friday Jun 30 | Daily Political

    Menta Capital LLC bought a new position in shares of Bio-Techne Corp during the first quarter, Holdings Channel reports. The fund bought 3,453 shares of the biotechnology company's stock, valued at approximately $351,000.

    Comment?

  13. Bio-Techne Corp (TECH) Stock Rating Upgraded by BidaskClubRead the original story w/Photo

    Thursday Jun 29 | IntersportsWire

    ... shares during the last quarter. 96.91% of the stock is currently owned by institutional investors. Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The ...

    Comment?

  14. Bio-Techne Corp (Tech) Shares Sold by Credit Agricole S aRead the original story w/Photo

    Wednesday Jun 28 | Daily Political

    Credit Agricole S A decreased its stake in shares of Bio-Techne Corp by 76.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,875 shares of the biotechnology company's stock after selling 26,155 shares during the period.

    Comment?

  15. Oppenheimer Asset Management Inc. Takes Position in Bio-Techne CorpRead the original story w/Photo

    Monday Jun 26 | Daily Political

    Oppenheimer Asset Management Inc. acquired a new position in shares of Bio-Techne Corp during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 12,371 shares of the biotechnology company's stock, valued at approximately $1,257,000.

    Comment?

  16. Bio-Techne Corp (TECH) Earns Media Sentiment Rating of 0.01Read the original story w/Photo

    Friday Jun 23 | IntersportsWire

    ... Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical Controls and Protein Platforms. The ...

    Comment?

  17. Papp L Roy & Associates Maintains Position in Bio-Techne CorpRead the original story w/Photo

    Thursday Jun 22 | IntersportsWire

    Papp L Roy & Associates continued to hold its position in Bio-Techne Corp during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,945 shares of the biotechnology company's stock at the end of the first quarter.

    Comment?

  18. BidaskClub Lowers Bio-Techne Corp (TECH) to HoldRead the original story w/Photo

    Wednesday Jun 21 | IntersportsWire

    TECH has been the subject of several other research reports. Zacks Investment Research cut Bio-Techne Corp from a "hold" rating to a "sell" rating in a research note on Wednesday, April 19th.

    Comment?

  19. Somewhat Negative Press Coverage Likely to Impact Bio-Techne Corp (TECH) Stock PriceRead the original story w/Photo

    Jun 19, 2017 | IntersportsWire

    ... stock worth $1,145,136 in the last 90 days. Company insiders own 2.70% of the company's stock. Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The ...

    Comment?

  20. Bio-Techne Corp (TECH) Receiving Positive News Coverage, Study ShowsRead the original story w/Photo

    Jun 18, 2017 | IntersportsWire

    News stories about Bio-Techne Corp have been trending positive on Sunday, AlphaOne reports. AlphaOne, a unit of Accern, scores the sentiment of media coverage by reviewing more than 20 million blog and news sources.

    Comment?